Security key
05337M104
Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)
CUSIP: 05337M104
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
- Total 13F shares
- 737,501
- Total 13F value
- $5,774,641
- Share change
- +500
- SEC-reported price per share
- $7.83
- Number of holders
- 3
- Value change
- +$3,915
- Number of buys
- 1
- Shares outstanding
- 98,762,388
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
3
Top holders
3
AVDL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
AVADEL PHARMACEUTICALS PLC SEC filings
AVADEL PHARMACEUTICALS PLC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05337M104
Recent filing periods:
Ownership snapshot
Top reported holders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Knoll Capital Management,...
Disclosed value leader
Knoll Capital Management,...
Comparable rows
3/5
Latest evidence
31 Dec 2024
13F
3/4/5
Lead comparable stake: 0.61%
2 rows are not safely comparable across share classes.
Quick read
Knoll Capital Management, LLC leads the comparable SEC ownership view at 0.61%.
3 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Knoll Capital Management, LLC's linked filing trail.
Comparable ownership
Top 3
Knoll Capital Management, LLC
0.61%
SCHULHOFF & CO INC
0.14%
HUNTINGTON NATIONAL BANK
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-5 of 5 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC |
13F
Company
|
0.61%
|
$6,306,000
600,000 shares
|
— | 31 Dec 2024 |
| SCHULHOFF & CO INC |
13F
Company
|
0.14%
|
$1,439,870
137,000 shares
|
— | 31 Dec 2024 |
| HUNTINGTON NATIONAL BANK |
13F
Company
|
0%
|
$16
1 shares
|
— | 31 Dec 2024 |
| Douglas J. Williamson |
3/4/5
Chief Medical Officer
|
—
class O/S missing
|
—
275,000 shares
|
— | 14 Feb 2022 |
| Richard J. Kim |
3/4/5
Chief Commercial Officer
|
—
class O/S missing
|
—
147,000 shares
|
— | 20 Feb 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
737,501
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2025 Across Filers
Q4 2025 holders
2
Q1 2025 holders
3
Holder diff
1
| Investor | Q4 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend